These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2500343)

  • 61. Non-infusional 5-fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinoma.
    Pentheroudakis G; Lim KC; Dunlop DJ; Soukop M; Eatock MM
    Acta Oncol; 2001; 40(7):855-61. PubMed ID: 11859986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy.
    Grosh WW; Jones HW; Burnett LS; Greco FA
    Gynecol Oncol; 1986 Nov; 25(3):334-9. PubMed ID: 3023205
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185).
    Kucuk O; Pandya KJ; Skeel RT; Hochster H; Abeloff MD
    Breast Cancer Res Treat; 1999 Sep; 57(2):201-6. PubMed ID: 10598047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
    Bensmaine M el-A ; Guillot T; Bernal ET; Janot F; Sigal R; Domenge C; Wibault P; Armand JP; Cvitkovic E
    Am J Clin Oncol; 1996 Aug; 19(4):356-62. PubMed ID: 8677904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site: a phase II trial.
    Guardiola E; Pivot X; Tchicknavorian X; Magne N; Otto J; Thyss A; Schneider M
    Am J Clin Oncol; 2001 Aug; 24(4):372-5. PubMed ID: 11474265
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.
    Taïeb J; Artru P; Baujat B; Mabro M; Carola E; Maindrault F; Tournigand C; Krulik M; Louvet C; de Gramont A
    Eur J Cancer; 2002 Mar; 38(5):661-6. PubMed ID: 11916548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
    Loeffler TM; Hausamen TU
    J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Treatment of advanced ovarian cancer].
    de Gramont A; Krulik M; Pigne A; Brissaud P; Sirinelli A; Hubert D; Zylberait D; Debray J
    Sem Hop; 1984 Mar; 60(14):957-60. PubMed ID: 6326283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
    Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
    Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research.
    Pouliquen X; Levard H; Hay JM; McGee K; Fingerhut A; Langlois-Zantin O
    Ann Surg; 1996 Feb; 223(2):127-33. PubMed ID: 8597505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
    Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
    Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Continuous infusion cisplatin and 5-fluorouracil with bolus vinorelbine in the treatment of advanced nonsmall cell carcinoma of the lung.
    Beuzeboc P; Livartowski A; Dierick A; Paraiso D; Pouillart P
    J Infus Chemother; 1995; 5(4):193-4. PubMed ID: 8934725
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
    Haim N; Tsalik M; Robinson E
    Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Kua VF; Ismail F; Chee Ee Phua V; Aslan NM
    Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
    Klaassen U; Wilke H; Seeber S
    J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.